These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6470960

  • 21. Cytochrome P450 oxidase activity and its role in NADPH dependent lipid peroxidation.
    Bast A, Brenninkmeijer JW, Savenije-Chapel EM, Noordhoek J.
    FEBS Lett; 1983 Jan 24; 151(2):185-8. PubMed ID: 6832351
    [Abstract] [Full Text] [Related]

  • 22. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily.
    Ciaccio PJ, Halpert JR.
    Arch Biochem Biophys; 1989 Jun 24; 271(2):284-99. PubMed ID: 2786372
    [Abstract] [Full Text] [Related]

  • 23. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R, Tolando R, King LJ, Manno M.
    Toxicol Appl Pharmacol; 1997 Apr 24; 143(2):420-8. PubMed ID: 9144458
    [Abstract] [Full Text] [Related]

  • 24. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT, Vasquez MT, Chiang CK.
    Biochem Pharmacol; 1991 Jun 01; 41(11):1691-9. PubMed ID: 2043158
    [Abstract] [Full Text] [Related]

  • 25. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM.
    Mutat Res; 1987 Oct 01; 182(5):231-41. PubMed ID: 3309638
    [Abstract] [Full Text] [Related]

  • 26. Metabolic deactivation of furylfuramide by cytochrome P450 in human and rat liver microsomes.
    Shimada T, Yamazaki H, Shimura H, Tanaka R, Guengerich FP.
    Carcinogenesis; 1990 Jan 01; 11(1):103-10. PubMed ID: 2403855
    [Abstract] [Full Text] [Related]

  • 27. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M, Field SL.
    Biochem Pharmacol; 1992 May 28; 43(10):2065-71. PubMed ID: 1599495
    [Abstract] [Full Text] [Related]

  • 28. Cytochrome P-450 metabolic-intermediate complex formation from p-aminobenzoic acid esters and other arylamines.
    Liu Z, Franklin MR.
    Eur J Drug Metab Pharmacokinet; 1984 May 28; 9(2):155-9. PubMed ID: 6611263
    [Abstract] [Full Text] [Related]

  • 29. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME, Minchin RF, Sanderson N, Wirth PJ, Thorgeirsson SS.
    Cancer Res; 1983 Aug 28; 43(8):3720-4. PubMed ID: 6861141
    [Abstract] [Full Text] [Related]

  • 30. Novel stereoselectivity of rat liver cytochrome(s) P450 toward enantiomers of the trans-1,2-dihydrodiol of triphenylene.
    Thakker DR, Boehlert C, Levin W, Ryan DE, Thomas PE, Yagi H, Jerina DM.
    Arch Biochem Biophys; 1991 Jul 28; 288(1):54-63. PubMed ID: 1898024
    [Abstract] [Full Text] [Related]

  • 31. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
    Murray M, Hetnarski K, Wilkinson CF.
    Xenobiotica; 1985 May 28; 15(5):369-79. PubMed ID: 4036165
    [Abstract] [Full Text] [Related]

  • 32. Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
    Pershing LK, Franklin MR.
    Xenobiotica; 1982 Nov 28; 12(11):687-99. PubMed ID: 6984805
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A, Savenije-Chapel EM, Kroes BH.
    Xenobiotica; 1984 May 28; 14(5):399-408. PubMed ID: 6089451
    [Abstract] [Full Text] [Related]

  • 34. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T, Fujita S, Narimatsu S, Masubuchi Y, Tachibana M, Ohta S, Hirobe M.
    FASEB J; 1992 Jan 06; 6(2):771-6. PubMed ID: 1537468
    [Abstract] [Full Text] [Related]

  • 35. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T, Matsuda H, Nagase K, Iwasaki K, Noda K, Yamazaki H, Shimada T, Funae Y.
    Biochem Pharmacol; 1994 Feb 11; 47(4):727-35. PubMed ID: 7510480
    [Abstract] [Full Text] [Related]

  • 36. Dealkylation of 7-methoxycoumarin as assay for measuring constitutive and phenobarbital-inducible cytochrome P450s.
    Reen RK, Ramakanth S, Wiebel FJ, Jain MP, Singh J.
    Anal Biochem; 1991 May 01; 194(2):243-9. PubMed ID: 1862930
    [Abstract] [Full Text] [Related]

  • 37. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.
    Dutton DR, Parkinson A.
    Arch Biochem Biophys; 1989 Feb 01; 268(2):617-29. PubMed ID: 2536534
    [Abstract] [Full Text] [Related]

  • 38. Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes.
    Marcus CB, Wilson NM, Jefcoate CR, Wilkinson CF, Omiecinski CJ.
    Arch Biochem Biophys; 1990 Feb 15; 277(1):8-16. PubMed ID: 2306127
    [Abstract] [Full Text] [Related]

  • 39. Cytochrome P-450 ligands: metyrapone revisited.
    Liu Z, Franklin MR.
    Arch Biochem Biophys; 1985 Sep 15; 241(2):397-402. PubMed ID: 4037796
    [Abstract] [Full Text] [Related]

  • 40. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
    Murray M, Butler AM.
    J Pharmacol Exp Ther; 1995 Feb 15; 272(2):639-44. PubMed ID: 7853177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.